A child has vomiting without diarrhea

INSTRUCTIONS for the use of the medicinal product for medical use Enterol®

Registration number: П N011277

Description: Smooth, shiny, opaque, white gelatin capsules № "0"containing light brown powder with a characteristic yeast odor.

Dosage Form: Capsules.

Composition. 1 capsule contains: Active ingredient: Lyophilized Saccharomyces boulardii 250 mg. Excipients: Lactose monohydrate, magnesium stearate, gelatin, titanium dioxide.

Pharmacotherapeutic group: antidiarrheal agent.

ATX code: [A07FA02]

Pharmacological properties

Sacramentora and others, as well as Entamoeba histolitica and Lambliae. Saccharomyces boulardii has an anti-toxin action against bacterial cyto- and enterotoxins, increases the enzymatic function of the intestine. Saccharomyces boulardii is naturally resistant to antibiotics.

After taking the drug Saccharomyces boulardii passes through the digestive tract unchanged without colonization. The drug is completely excreted from the body within 2-5 days after discontinuation.

Treatment and prevention of diarrhea of ​​any etiology.

Contraindications

1. Hypersensitivity to one of the components; 2. The presence of a central venous catheter, as described rare cases of fungi in patients with a central venous catheter in hospital conditions.

Dosage and administration

Children from 1 year to 3 years – 1 capsule twice a day for 5 days.

Children from 3 years and adults – 1-2 capsules twice a day for 7-10 days. Enterol® should be taken 1 hour before meals with a small amount of liquid. Do not drink hot and alcoholic beverages. For young children, as well as in cases of difficulty swallowing, the capsule can be opened and given its contents with a cold or slightly warm liquid. The drug for the treatment of acute diarrhea must be accompanied by rehydration.

Side effect

In rare cases, individual sensitivity to the components of the drug may occur.

Pregnancy and lactation

Use of Enterola® during pregnancy or lactation is justified if the expected benefit outweighs the potential risk.

special instructions

If, after two days of use of Enterol® for the treatment of acute diarrhea, there is no improvement, as well as with a rise in temperature, detection of blood or mucus in the stool, it is necessary to immediately contact your doctor. The sensation of thirst and dry mouth indicates insufficient rehydration.

Drug interaction

Release form

On 10, 20, 30 or 50 capsules in a bottle from transparent glass with a polyethylene cover and a protective film. On 1 bottle with the application instruction in a cardboard box.

On 5 capsules in the blister from PA / aluminum / PVC and aluminum foil. On 2, 4 or 6 blisters with the application instruction in a cardboard box.

6 capsules per blister of PA / aluminum / PVC and aluminum foil. On 5 blisters with the application instruction in a cardboard box.

Storage conditions

At a temperature of 15-25 o С, out of the reach of children.

Shelf life

3 years. Do not use after the date indicated on the package.

Pharmacy sales terms

Manufacturer

Biocodex, 7, avenue Gallieni, 94250 Gentilly, France

Biocodex, 7, Gallieny Avenue, 94250 Zhantiyi, France

Registration Certificate Holder

Biocodex, 7, Avenue Gallieny, 94250 Zhantiyi, France.

Biocodex, 7, avenue Gallieni, 94250 Gentilly, France

You can receive additional information about the preparation, as well as send your claims and information about undesirable effects to the following address in Russia: LLC BIOKODEX 107045 Moscow, 11 Pervy Lane, 11, bldg. 1 Tel .: +7 (495 ) 783-26-80 Fax: +7 (495) 783-26-81 E-mail: phv @

INSTRUCTIONS for the use of the medicinal product for medical use Enterol®

Registration number: LP-002433

Trade name: Enterol®

Dosage form: powder for suspension for oral administration

Ingredients: 1 sachet contains: Active ingredient: Saccharomyces boulardii lyophilisate 250 mg; Auxiliary components: lactose monohydrate 32.5 mg, fructose 471.9 mg, colloidal silicon dioxide 6.25 mg, tutti-frutti flavoring 4.35 mg.

Description: Light brown powder with fruit aroma.

Pharmacotherapeutic group: Antidiarrheal agent

ATC code: A07FA02

Pharmacological properties

The drug Saccharomyces boulardii is a probiotic, as defined by WHO, these are live microorganisms, applied in adequate quantities, providing a health effect on the human body. Saccharomyces boulardii others, as well as Entamoeba histolytica and Lambliae. Saccharomyces boulardii has an anti-toxin action against bacterial cyto- and enterotoxins, increases the enzymatic function of the intestine. The cell wall component of Saccharomyces boulardii mannitol is a substrate for pathogenic strains of Escherichia coli and Salmonella typhimurium, which causes their adhesion (attachment) to the surface of Saccharomyces boulardii and subsequent elimination from the body. Saccharomyces boulardii is naturally resistant to antibiotics.

Saccharomyces boulardii is not a eubiotic,

Indications for use

Treatment and prevention of diarrhea of ​​various etiologies in adults and children from 1 year, in

Contraindications

Hypersensitivity to any of the components of the drug.

The presence of a central venous catheter, as described rare cases of fungemia in patients with a central venous catheter in hospital conditions.

A child has vomiting without diarrhea

Lactose intolerance, lactase deficiency, glucose-galactose malabsorption.

Use during pregnancy and during breastfeeding

Data on the safety of the drug in pregnant women and during breastfeeding are not available. The use of the drug is possible if the intended benefit to the mother outweighs the potential risk to the fetus.

Dosage and administration

Inside on 1 or 2 bags of 1 or 2 times a day for 1 hour before meals. The contents of the bag can be mixed with water or another drink, as well as added to food or in a bottle with baby food.

Children from 1 to 3 years old – 1 sachet twice a day.

Children from 3 years old and adults – 1-2 sachets twice a day.

For the treatment of acute diarrhea of ​​viral, bacterial or protozoal etiology, the course of treatment is 5-10 days.

For the prevention of antibiotic-associated diarrhea, a day-to-day course of treatment corresponds to the course of antibiotic use.

For the prevention of recurrence of infection caused by Clostridium difficile, in combination with metronidazole or vancomycin, the treatment is 1 month.

For the prevention of travelers’ diarrhea, the daily treatment course corresponds to the duration of the trip.

For the treatment of irritable bowel syndrome, the use of the drug should be continued until the symptoms disappear.

The drug for the treatment of acute diarrhea must necessarily be accompanied by rehydration (heavy drinking).

Side effect

In rare cases, individual sensitivity to the components of the drug may occur.

If you notice any other side effects that are not listed in the instructions, inform your doctor.

Overdose

Data on overdose of the drug is not currently available.

Interaction with other drugs

Enterol is not taken in conjunction with antifungal drugs. Compatible with antibiotics.

special instructions

It is necessary to use the drug with caution in persons with immunodeficiency.

Do not drink hot and alcoholic beverages. Do not heat the product mixed in water or other beverage in the microwave oven (microwave). Water or drink, if necessary, is heated in a microwave oven, and then add the drug in warm water.

If after two days of use of the drug Enterol® for the treatment of acute diarrhea does not improve, as well as with increasing temperature, detecting blood or mucus in the stool, you should immediately contact your doctor. The sensation of thirst and dry mouth indicates insufficient fluid intake (rehydration).

The preparation, the integrity of the packaging of which is broken, the preparation without labeling, the preparation with altered physical properties, is unsuitable for use.

Impact on the ability to drive vehicles and mechanisms

There was no adverse effect of the use of Enterol® on the ability to drive a car and complex mechanisms.

Release form

Powder for the preparation of suspensions for ingestion of 250 mg: 765 mg of powder are placed in a paper-polyethylene-aluminum bag. On 10 or 20 bags together with the application instruction are placed in a pack cardboard. On 6 bags place in a pack cardboard without the top side and on 5 such packs place in a pack cardboard together with the instruction for application.

A child has vomiting without diarrhea

Storage conditions

At a temperature of 15 to 25 o C. Keep out of the reach of children.

A child has vomiting without diarrhea

Shelf life

3 years. Do not use after the date indicated on the package.

Vacation conditions

Over-the-counter

Manufacturer and owner of registration certificate

Biocodex, 7, avenue Gallieni, 94250 Gentilly, France Biocodex, 7, Avenue Gallieny, 94250 Zhantiyi, France

Address of production:

1, avenue Blaise Pascal, 60000 Beauvais, France 1, Avenue Blaise Pascal, 60000 Beauvais, France

Like this post? Please share to your friends:
Leave a Reply